Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antiviral drug
|
| gptkbp:approvalYear |
1982
|
| gptkbp:ATCCode |
J05AB01
|
| gptkbp:CASNumber |
59277-89-3
|
| gptkbp:chemicalFormula |
C8H11N5O3
|
| gptkbp:discoveredBy |
gptkb:Howard_Schaeffer
|
| gptkbp:eliminationHalfLife |
2.5 to 3.3 hours
|
| gptkbp:excretion |
renal
|
| gptkbp:FDAApproved |
Yes
|
| gptkbp:genericName |
gptkb:acyclovir
|
| https://www.w3.org/2000/01/rdf-schema#label |
Zovirax
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
GlaxoSmithKline
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:routeOfAdministration |
oral
topical intravenous |
| gptkbp:sideEffect |
nausea
vomiting diarrhea headache rash |
| gptkbp:usedFor |
gptkb:chickenpox
shingles herpes simplex virus infections varicella zoster virus infections |
| gptkbp:bfsParent |
gptkb:GSK
gptkb:Valeant_Pharmaceuticals gptkb:acyclovir |
| gptkbp:bfsLayer |
6
|